Coccidioidomycosis primary prevention: Difference between revisions
Jump to navigation
Jump to search
Aditya Ganti (talk | contribs) |
Aditya Ganti (talk | contribs) |
||
| Line 4: | Line 4: | ||
{{CMG}}; {{AE}}; {{VB}}; {{ADG}} | {{CMG}}; {{AE}}; {{VB}}; {{ADG}} | ||
==Overview== | ==Overview== | ||
There are no primary preventive measures available for Coccidioidomycosis. A vaccine is in developmental stages but is not yet available for clinical use. | There are no primary preventive measures available for Coccidioidomycosis. A vaccine is in developmental stages but is not yet available for clinical use. Avoidance of geographic locations where the disease is endemic is recommended, but this is usually not applicable in practice. | ||
==References== | ==References== | ||
Revision as of 18:13, 28 March 2017
|
Coccidioidomycosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Coccidioidomycosis primary prevention On the Web |
|
American Roentgen Ray Society Images of Coccidioidomycosis primary prevention |
|
Risk calculators and risk factors for Coccidioidomycosis primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: ; Vidit Bhargava, M.B.B.S [2]; Aditya Ganti M.B.B.S. [3]
Overview
There are no primary preventive measures available for Coccidioidomycosis. A vaccine is in developmental stages but is not yet available for clinical use. Avoidance of geographic locations where the disease is endemic is recommended, but this is usually not applicable in practice.